Evidence-Based Gastroenterology and Hepatology
The only evidence-based resource combining gastroenterology and hepatology, this major textbook criticallyappraises the evidence for diagnosis, screening, and treatment ofgastrointestinal and hepatic diseases, and provides clearrecommendations for management.A unique feature is the grading of both the evidence (randomizedcontrolled trials, systematic reviews, or lower quality trials) andthe treatment recommendations. This structure provides the readerwith valuable guidance on implementation.The third edition has been fully revised, providing thelatest reviews of the evidence. It is also enhanced with newtopics that have significant evidence f…
Mehr
CHF 270.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
Produktdetails
Weitere Autoren: Feagan, Brian G. (Hrsg.) / McDonald, John W. D. (Hrsg.) / Fennerty, M. Brian (Hrsg.)
- ISBN: 978-1-4443-1441-0
- EAN: 9781444314410
- Produktnummer: 13894073
- Verlag: Wiley
- Sprache: Englisch
- Erscheinungsjahr: 2010
- Seitenangabe: 824 S.
- Plattform: PDF
- Masse: 10'189 KB
- Auflage: 3. Aufl.
Über den Autor
John McDonald, Professor of Gastroenterology at the University of Ontario, London Ontario, Coordinating Editor in the Cochrane Collaboration Steering Committee on methodology, and Past President of the Canadian College of Gastroenterology Professor Andrew Burroughs MBChB Hons FRCPConsultant Physician and Hepatologist, Royal Free Hospital, London, has an international reputation as a clinical and academic Hepatologist and has published widely in all areas of liver disease. He is a full time clinician and has been awarded a personal chair, as Professor of Hepatology in the University of London. Brian Feagan is Professor of Medicine and Epidemiology and Biostatistics at the University of Western Ontario. He holds cross-appointments in the Divisions of Internal Medicine, Clinical Pharmacology and Gastroenterology. He is a specialist in Internal Medicine with training in Clinical Epidemiology and Gastroenterology who has been the lead investigator in the design and implementation of randomized controlled trials since 1986. In addition to being an internationally recognized expert in the therapy of Inflammatory Bowel Disease, Dr. Feagan has conducted trials on behalf of Industry and peer-reviewed agencies in a wide range of disease states. Dr. Feagan is interested in the evaluation of Health Related Quality of Life (HRQL) and has performed research on the operating properties of HRQL instruments. M Brian Fennerty, Professor of Medicine, Division of Gastroenterology, Oregon Health and Science, University of Oregon, USA.
1 weiteres Werk von Andrew K. (Hrsg.) Burroughs:
Bewertungen
Anmelden